Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

RCT Targeting Cognition in Early Alzheimer's Disease by Improving Sleep With Trazodone (REST)

NCT05282550 is registered in ClinicalTrials.gov with Johns Hopkins University as lead sponsor.

NCT NCT05282550
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05282550 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
RCT Targeting Cognition in Early Alzheimer's Disease by Improving Sleep With Trazodone (REST)
Lead sponsor
Johns Hopkins University
Phase
Phase 2
Overall status
Recruiting
Start date
February 2, 2023
Completion date
June 30, 2028
Enrollment
100 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

amci - amnestic mild cognitive impairment, sleep disturbance